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Abstract
Background: As imaging centers produce higher resolution research scans, the number of man-hours required
to process regional data has become a major concern. Comparison of automated vs. manual methodology has
not been reported for functional imaging. We explored validation of using automation to delineate regions of
interest on positron emission tomography (PET) scans. The purpose of this study was to ascertain improvements
in image processing time and reproducibility of a semi-automated brain region extraction (SABRE) method over
manual delineation of regions of interest (ROIs).
Methods: We compared 2 sets of partial volume corrected serotonin 1a receptor binding potentials (BPs)
resulting from manual vs. semi-automated methods. BPs were obtained from subjects meeting consensus criteria
for frontotemporal degeneration and from age- and gender-matched healthy controls. Two trained raters
provided each set of data to conduct comparisons of inter-rater mean image processing time, rank order of BPs
for 9 PET scans, intra- and inter-rater intraclass correlation coefficients (ICC), repeatability coefficients (RC),
percentages of the average parameter value (RM%), and effect sizes of either method.
Results: SABRE saved approximately 3 hours of processing time per PET subject over manual delineation (p <
.001). Quality of the SABRE BP results was preserved relative to the rank order of subjects by manual methods.
Intra- and inter-rater ICC were high (>0.8) for both methods. RC and RM% were lower for the manual method
across all ROIs, indicating less intra-rater variance across PET subjects' BPs.
Conclusion: SABRE demonstrated significant time savings and no significant difference in reproducibility over
manual methods, justifying the use of SABRE in serotonin 1a receptor radioligand PET imaging analysis. This
implies that semi-automated ROI delineation is a valid methodology for future PET imaging analysis.
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Background
Advances in functional neuroimaging techniques have
allowed the correlation of regions of interest (ROIs) with
behavioral and cognitive tasks. Manual delineation of
ROIs by trained operators is still considered the "gold
standard," given its precision for the targets; however
some drawbacks of manual analysis have recently been
pointed out, such as its labor-intensive requirements (i.e.,
extensive time needed for ROI drawing) [1], limited
reproducibility [2], and difficulties in measuring cortical
ROIs [3]. In order to resolve these problems, some
researchers have suggested other methods of analysis as
represented by an automated program to label brain
regions [4], automated evaluation of the whole brain [5],
and automated voxel-based morphometry [6]. Unfortu-
nately, these alternatives also are limited by ROIs availa-
ble [4,5] and the potential inaccuracy introduced by
spatial normalization of the brain [7]. The semiautomatic
brain region extraction (SABRE) method was designed by
Dade et al. to minimize the errors of both manual and
automated analysis [1].
SABRE combines manual and automated analyses, which
maximizes the advantages of both methods by manual
definition of the most essential landmarks to create a cus-
tomized atlas for the individual brain and automatic
brain parcellation. SABRE has proven reliable in assessing
regional tissue volume, and it provides time savings over
purely manual methods.
The present study compares the benefits of the SABRE
method to manual ROI delineation. We searched Pubmed
for similar studies using the search terms: "automated
brain region extraction," "brain region extraction," "man-
ual ROI AND automated," "region of interest delinea-
tion," "SABRE," "semiautomated brain region extraction,"
and "semiautomatic brain region extraction." This yielded
491 citations. Of these, 5 described research questions
similar to ours [8-11]. Three studies reported the effects of
semi-automated methods vs. manual delineation meth-
ods for structural or volumetric MRI results for limited
regions of brain such as hippocampus [10,11] or ventricu-
lar cerebrospinal fluid volume [9]. One of the hippocam-
pal studies required manual delineation on the subject's
first MRI, then used automated algorithms to gauge longi-
tudinal volumetric changes from the original, individual-
ized template [11]; the other hippocampal study used a
novel expanding seed voxel with constraint points to
identify 3D volumes of interest from the inside out [10].
Mosconi et al. validated automated voxel-based FDG-PET
analysis including spatial normalization of hippocampal
probability ROIs [12]. Only Mega et al. described a parcel-
lation of brain into cortical regions as SABRE does [8].
Their sample also included subjects with cortical atrophy
due to neurodenegerative processes but the imaging proc-
ess requires warping to a standardized volumetric brain-
space. Studies comparing ROI extraction reported positive
conclusions in favor of using automation to save time
[8,10,11] or achieving similar accuracy to manual meth-
ods [8-11], but none of them have validated the use of
semi-automated methods to process functional imaging
data or to process multiple cortical regions without warp-
ing. During the revision of this manuscript for publica-
tion, a paper describing a fully automated ROI extraction
for use with PET imaging was published by Rusjan et al.
[35]. The authors devised a fully automated method
which showed time savings over manual methods and
very high intraclass correlation between the two methods
for use with three different radioligands. This method
does not allow for individualization of intracranial capac-
ity as in SABRE, which will be discussed below.
This study is a first time application of SABRE to a posi-
tron emission tomography (PET) study of patients with
frontotemporal degeneration (FTD). As PET scanners
evolve to yield larger numbers of image slices, the man-
hours required to delineate ROIs for each subject become
impractical. We wished to validate the use of SABRE in
analyzing our PET data. Assuming that manual analysis is
the gold standard, we compared the PET results generated
by manual ROI drawing to those by SABRE, on the bases
of analysis time, effect of analysis method on PET results,
reproducibility, and ability to discriminate FTD patients
from healthy control subjects. We hypothesized that
SABRE would save image processing time without altering
the basic quality of PET results but that SABRE would be
less sensitive to detect the differences between an FTD
patient group and an age-matched healthy comparison
group. We also hypothesized that SABRE's test-retest
reproducibility would be superior to the manual method,
which might compensate for any loss of sensitivity. Bal-
ancing these characteristics might allow investigators to
choose the more feasible and statistically useful procedure
for future PET analyses of an FTD population.
Methods
Participants
We used data from 9 participants in a study comparing
serotonin 1a receptor (5-HT1aR) density as estimated by
radioligand binding potentials (BPs) from PET imaging
data [13]. We studied 5 patients with FTD diagnosed by
consensus criteria [14], duration 3–6 years. They were 1
man and 4 women, ages ranging 59–79 years, with MMSE
scores 16–30, and CDR scores of 0.5). We also studied 4
age- and gender-matched healthy comparison subjects (1
man and 3 women, age range 63–80 years). The study
procedures were reviewed and approved by Research Eth-
ics Boards at all participating institutions. All 9 subjects or
their substitute decision makers gave informed consent to
participate in the study.BMC Nuclear Medicine 2007, 7:2 http://www.biomedcentral.com/1471-2385/7/2
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MRI data acquisition
Imaging procedures: We conducted structural MR imaging
on a 1.5 T Signa research-dedicated scanner (GE Medical
Systems, software v. 8.4M4, with CV 40 mT/m gradients)
at Sunnybrook Health Sciences Centre. We acquired a
high-resolution T1-weighted image (an axial 3D SPGR
with 5 ms TE, 35 ms TR, 1 NEX, 35° flip angle, 22 × 16.5
cm FOV, 0.859 × 0.859 mm in-plane resolution, and 1.2
to 1.4 mm slice thickness depending on head size). This
was followed by an interleaved proton density (PD) and
T2-weighted image set (an interleaved axial spin echo
with TEs of 30 and 80 ms, 3s TR, 0.5 NEX, 20 × 20 cm
FOV, 0.781 × 0.781 mm in-plane resolution, and 3 mm
slice thickness). The T1-weighted and PD/T2-weighted
imaging parameters have been selected to provide opti-
mal intensity separation and are routinely used for tissue
segmentation [15].
Serotonin 1a receptor (5-HT1aR) PET acquisition
PET scans with the radioligand [11C]WAY-100635, a 5-
HT1aR antagonist, were performed within 3 months of
the MRI scans. Specific activity at time of intravenous
injection of the radioligand averaged 793 ± 373 mCi/
μmol. PET images were acquired for 15 transaxial slices
(slice thickness of 6.5 mm) over 90 minutes with a GE
Medical System PC-2048-15B camera with 5.5 mm intrin-
sic resolution FWHM.
Co-registered MR and PET images were used for semi-
automated and manual ROI delineation, as described
below.
Manual region of interest delineation
We co-registered T1 MR images to the summed PET
frames with Rview software [16], then hand-drew ROIs
manually on the co-registered T1 images with the Alice™
software (Perceptive Informatics, Waltham, Massachu-
setts), based on previously defined landmarks (refer to
Appendix I, see Additional file 1) [17-22]. Based on the
proximity to the SABRE ROIs, the following twelve man-
ual ROIs were used to generate the TACs of brain uptake:
frontal lobe, orbitofrontal cortex (OFC), dorsolateral pre-
frontal cortex (DLPFC), anterior lateral temporal lobe
(ALT), and middle amygdala-anterior parahippocampus
(medial temporal) (10 ROIs across both hemispheres).
Two well-trained technicians, CP (Rater M1) and PSJ
(Rater M2), hand-drew ROIs.
Cortical atrophy challenges the accurate interpretation of
functional images from patients with dementia. A partial
volume correction (PVC) method has been adapted to
correct WAY-PET imaging resolution issues. The PVC algo-
rithm corrects for atrophy, spill-in effects, and spill-out
effects. This is a variation of the algorithm by Bencherif et
al. [23], modified so that calculations are performed in
higher-resolution MR space. The algorithm was used to
create a map of gray matter (GM) vs. non-GM pixels for
each subject. We then applied the hand-drawn ROIs to the
map and used Alice™ to calculate average correction fac-
tors for each ROI. We submitted the initially derived BPs
to their corresponding correction factors and report here
the corrected BPs.
SABRE ROI delineation
The SABRE method uses a robust tissue segmentation pro-
tocol, which accounts for regional field (RF) inhomoge-
neities, noise, and partial volume effects [15]. When
tested using the Montreal Neurological Imaging phan-
tom, the coefficient of total agreement with increased
noise and RF inhomogenity levels was 0.97. When tested
on young normal controls and elderly Alzheimer's disease
patients, the maximal differences were less than 1% of
total intracranial capacity in all tissue classes in a scan-res-
can test.
The SABRE process begins with segmentation of the MRI
data into GM, white matter, ventricular cerebral spinal
fluid and subdural/sulcal CSF (ssCSF) [1,15]. In fact, these
segmentation data were used for the PVC algorithm
described above. First, the operator subtracted the non-
brain tissue (e.g., skull) from the T1 MR images to extract
the T1 intracranial cavity (T1 eroded images). Identifica-
tion of 15 landmarks on the 3D-rendered T1 images (e.g.,
anterior commissure (AC), central sulcus) with ANALYZE
software (Biomedical Imaging Resource, Mayo Clinic,
Rochester, Minnesota) yields a proportional Talairach
grid of each individual's eroded T1 images [1]. Using the
resulting proportional grid and defined landmarks, the
SABRE program parcellates the eroded T1 images auto-
matically into 26 zones (13 in each hemisphere).
To convert the SABRE zones into ROIs, we used AIR (ver-
sion 5.5) to yield the optimal matrix for co-registration of
the T1 masked images to the summed 0–90 minute PET
frames (15 transaxial slices) [24]. We restricted the SABRE
zones to GM-only portions, outlining them automatically
with ANALYZE, because SABRE zones must be converted
from opaque square fields to ALICE-compatible outlines.
See figure 1 for an illustration of manual vs. SABRE-gener-
ated outlines of ROIs.
The same SABRE ROIs were applied to the grey matter vs.
non-GM PET data map to derive SABRE-specific average
correction factors for each ROI. These were then applied
to the TAC data to derive the second set of partial volume
corrected BPs for comparison to the manual ROI data.
These procedures were performed by a neurosurgeon (ST,
Rater S1) and a highly trained technician (JR, Rater S2).BMC Nuclear Medicine 2007, 7:2 http://www.biomedcentral.com/1471-2385/7/2
Page 4 of 11
(page number not for citation purposes)
Derivation of binding potential (BP)
Manual and SABRE ROIs became the overlays applied to
the dynamic PET images to calculate BP values of each
ROI with Alice and PKIN/PMOD software (PMOD group,
Zürich, Switzerland) [25,26]. A simplified reference tissue
method (SRTM) was performed to obtain BP values, using
the cerebellum as the input function [27], given previous
findings that the cerebellum is relatively devoid of
5HT1aR [28] and that this method has been proven to be
superior to kinetic modeling using arterial data [29].
Statistics
Because the BP itself is a relative estimation, and the
SABRE regions are inexact proxies of the hand-drawn
ROIs, we did not seek direct correlations between BPs
from manual vs. SABRE ROIs. Instead, we compared the
methods with regard to: 1) image processing time, 2)
basic quality of PET results, 3) reproducibility of BP
results, and 4) sensitivity to differentiate FTD patients
from comparison subjects based on BP results.
Manual raters (M1 and M2) and SABRE raters (S1 and S2)
delineated ROIs on the imaging data a total of 6 times.
Raters M1 and S1 repeated the process to yield the follow-
ing sets of 5HT1aR BP values: M1A, M1B, M2; S1A, S1B,
S2.
We averaged inter-rater processing times for each method
(i.e., (M1A +M2)/2 and (S1A +S2)/2), then compared the
mean time spent to process the data using either manual
or SABRE methods with the unpaired Student's t-test, as
we expected SABRE to save time.
We evaluated the basic quality of PET results by calculat-
ing the over all rank order of BPs among 9 subjects in each
ROI with the Spearman rank correlation test. We calcu-
lated ratios of BPs in the left regions to those of the corre-
sponding right regions (L/R ratios) for comparison of the
two methods with the Wilcoxon signed rank test.
We assessed the reproducibility of the tested analysis
methods based on intra- and inter-rater reliability for the
BPs. We rated intra-rater reliability using intraclass corre-
lation coefficients (ICC), repeatability coefficients (RC),
and percentages of the average parameter value (RM%, a
measure of coefficient of variation of the difference
between the methods). ICC were based on the 1st and 2nd
results generated by the same rater (M1A vs. M1B and S1A
vs. S1B). To determine RM%, we first calculated the RC as
twice the standard deviation (SD) of the difference
between the average BP values for each of the ROIs from
the 1st and 2nd analyses (e.g., M1A and M1B), expecting
95% of the differences to be less than the RC [30]. In addi-
tion, to facilitate comparisons across regions, the RC was
calculated as percentage of the mean BP to obtain the
RM% [27]:
Inter-rater reliability was assessed by calculating ICC
between manual results M1A vs. M2 and SABRE results
from S1A vs. S2. We used SPSS: Analysis: Scale: Reliability:
Statistics – ICC to make these calculations. We used the
Wilcoxon signed rank test to compare the resulting aver-
age ICC for manual vs. SABRE results.
Sensitivity to differentiate FTDs from controls
We used two indicators to assess the ability of the meth-
ods to differentiate FTD patients from healthy compari-
son subjects. At autopsy, FTD patients have significant
reductions in serotonin receptor densities [31,32]; we
expected to find similar losses, reflected as lower BPs, dur-
ing the course of illness. First we compared the mean BPs
for each ROI with paired t-tests. We also defined Cohen's
measures for the effect size (d) as the average BP value for
the FTD group minus that for comparison subjects
divided by the standard deviation for the pooled samples
[33]. We compared the calculated d values between man-
ual and SABRE methods with the Wilcoxon signed rank
test.
We used SPSS (version 15.0, SPSS, Inc., Chicago, Illinois)
for all statistical analyses.
Results
Table 1 shows the range of mean 5-HT1a R BP values.
Mean BPs after partial volume correction were similar
between manual and SABRE methods, without significant
differences between FTD and control BPs.
Imagine processing time
The image processing time for SABRE had statistically and
practically significant savings over the manual method (p
< 0.0001): S1A/S2 1.2 ± .08 hours per subject vs. M1A/M2
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SD BPscan BPscan
Mean BPscan BPscan
%
()
()
% =
×−
+
×
21 2
12
100
Region of interest delineation: a) manual, b) using SABRE Figure 1
Region of interest delineation: a) manual, b) using SABRE.B
M
C
 
N
u
c
l
e
a
r
 
M
e
d
i
c
i
n
e
 
2
0
0
7
,
 
7
:
2
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
3
8
5
/
7
/
2
P
a
g
e
 
5
 
o
f
 
1
1
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 1: Average regional 5-HT1a receptor BP values
Manual
Patients Comparison Subjects
M1A M1B M2 M1A M1B M2
Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt
Frontal lobe 3.64 ± 1.89 3.57 ± 1.91 3.81 ± 2.11 3.71 ± 2.10 4.96 ± 2.07 4.96 ± 2.27 3.49 ± 0.93 3.47 ± 0.64 3.53 ± 0.86 3.47 ± 0.64 5.52 ± 1.46§ 4.98 ± 1.00
OFC 5.01 ± 3.92 4.34 ± 4.35 4.89 ± 3.95 4.36 ± 4.47 5.62 ± 3.07 5.01 ± 3.43 5.38 ± 0.95 5.92 ± 1.12 5.52 ± 1.14 5.86 ± 1.11 6.12 ± 1.05 6.47 ± 1.12
DLPFC 3.87 ± 1.77 3.89 ± 1.96 3.77 ± 1.87 3.80 ± 2.06 4.70 ± 1.91 4.92 ± 2.17 3.92 ± 1.10 3.79 ± 0.61 3.78 ± 1.07 3.64 ± 0.70 4.34 ± 0.94 4.48 ± 0.87
Ant. Lat. Temporal lobe 5.25 ± 1.37 5.81 ± 2.23 5.09 ± 1.55 5.47 ± 2.39 7.58 ± 2.92 7.36 ± 1.98 5.52 ± 1.12 5.93 ± 1.27 5.37 ± 1.36 5.62 ± 1.02 5.97 ± 1.17 6.18 ± 1.02
Medial Temporal 4.58 ± 2.35 5.04 ± 2.71 4.88 ± 1.98 4.98 ± 2.64 4.97 ± 2.69 5.20 ± 2.57 4.61 ± 1.85 5.42 ± 1.25 4.48 ± 1.65 5.38 ± 1.36 5.58 ± 2.30 6.15 ± 1.90
Average 4.47 4.53 4.49 4.46 5.57 5.49 4.58 4.91 4.54 4.79 5.51 5.65
SABRE
Patients Comparison Subjects
S1A S1B S2 S1A S1B S2
Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt
Frontal lobe 4.09 ± 1.68 3.83 ± 1.79 3.85 ± 2.27 3.61 ± 2.36 3.99 ± 1.60 3.71 ± 1.77 4.67 ± 1.29 4.58 ± 1.24 4.55 ± 1.00 4.47 ± 0.94 4.49 ± 1.14 4.43 ± 1.10
OFC 4.07 ± 2.57 3.54 ± 2.73 3.91 ± 3.06 3.45 ± 3.18 4.01 ± 2.59 3.26 ± 2.94 5.50 ± 1.01 4.86 ± 1.03 5.57 ± 0.83 5.03 ± 0.98 5.23 ± 0.86 5.19 ± 1.39
DLPFC 4.04 ± 1.46 3.90 ± 1.48 3.78 ± 2.04 3.62 ± 2.04 4.73 ± 1.44 4.09 ± 1.54 4.27 ± 1.30 4.34 ± 1.01 4.32 ± 1.19 4.44 ± 0.96 5.61 ± 2.91 5.96 ± 2.94
Ant. Lat. Temporal lobe 5.07 ± 1.63 5.06 ± 1.61 4.74 ± 2.16 4.74 ± 2.22 4.89 ± 1.44 4.90 ± 1.50 5.42 ± 1.37 5.36 ± 1.28 5.25 ± 1.02 5.18 ± 0.89 5.27 ± 1.21 5.10 ± 1.05
Medial Temporal 5.32 ± 3.19 5.82 ± 1.98 5.61 ± 2.49 5.39 ± 2.44 5.68 ± 1.89 5.62 ± 1.83 5.95 ± 1.13 5.85 ± 0.64 6.11 ± 0.89 6.14 ± 0.66 9.19 ± 1.16 6.00 ± 0.90
Average 4.52 4.43 4.38 4.16 4.59 4.31 5.16 5.00 5.16 5.05 5.36 5.34
§indicates average ± SDBMC Nuclear Medicine 2007, 7:2 http://www.biomedcentral.com/1471-2385/7/2
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5 ± 0.75 hours per subject; S1B/S2 1.2 ± .08 hours vs.
M1B/M2 3.5 ± 0.3 hours.
Basic quality of PET results
We found significant positive correlations between the
rank order of BPs among the 9 tested subjects in the
majority of rater × method comparisons, but measure-
ments for anterior lateral and medial temporal regions
were less similar (see Table 2).
In the comparison of L/R ratios of BPs, the orbitofrontal
cortex (OFC) showed the highest average L/R ratio in both
manual and SABRE results for all 6 raters' measurements
of BPs (see Table 3). One subject had a very small right
OFC, which led to higher variance in both manual and
SABRE measurements. When this subject's data were
excluded, the SABRE average for raters S1A, S1B, and S2
were more similar at 1.16, 1.15, and 1.13, respectively.
Most L/R ratios were very close to 1.0. After excluding the
outlier, there were no statistically significant Wilcoxon
results.
Reproducibility of BP results
SABRE methods achieved average intra-rater (S1A vs. S1B)
ICC values similar to the manual methods (see Table 4),
but Wilcoxon rank testing showed significant differences
in average RC and RM%, supporting manual methods as
more reliable when examining intra-rater performance. As
shown in the table, the RM% had a wide range across
ROIs.
SABRE results yielded high ICC values for inter-rater relia-
bility in general (see Table 5). Average SABRE ICC ranged
from 0.91 – 0.97 on both hemispheres, with lower ICC for
DLPFC ROIs. Rater S2's BP results for DLPFC from one
control were exceptionally large (~9.5 vs. ~5). When the
data for this subject were excluded, ICC for this ROI
increased to 0.83, 0.79, 0.85, and 0.85, reading left to
right across Table 5.
In comparison, ICC values for the manual method were
slightly lower averages, ranging 0.79–0.87. As opposed to
the DLPFC, the lowest ICC for the manual ratings were in
Table 2: Correlations between 5-HT1aR BP values from manual versus SABRE ROI analysis (Spearman rs values) were statistically 
significant (p < .05) except where noted.
S1A vs M1A S1A vs M1B S1A vs M2 Row Average
Lt Rt Lt Rt Lt Rt Lt Rt
Frontal lobe 0.80 0.93 0.90 0.88 0.75 0.97 0.82 0.93
OFC 0.82 0.93 0.83 0.93 0.78 0.87 0.81 0.91
DLPFC 0.87 0.88 0.88 0.78 0.85 0.67 0.87 0.78
Ant. Lat. Temporal lobe 0.95 0.90 0.93 0.82 0.63 0.67 0.84 0.79
Medial Temporal 0.58 0.85 0.60 0.80 0.68 0.52† 0.62 0.72
Column Average 0.80 0.90 0.83 0.84 0.74 0.74 0.79 0.83
S1B vs M1A S1B vs M1B S1B vs M2
Lt Rt Lt Rt Lt Rt
Frontal lobe 0.82 0.90 0.95 0.85 0.75 0.95 0.84 0.90
OFC 0.82 0.80 0.83 0.80 0.78 0.88 0.81 0.83
DLPFC 0.92 0.85 0.93 0.85 0.88 0.78 0.91 0.83
Ant. Lat. Temporal lobe 0.90 0.95 0.88 0.87 0.70 0.53† 0.83 0.78
Medial Temporal 0.42† 0.85 0.33† 0.83 0.50† 0.72 0.42 0.80
Column Average 0.77 0.87 0.79 0.84 0.72 0.77 0.76 0.83
S2 vs M1A S2 vs M1B S2 vs M2
Lt Rt Lt Rt Lt Rt
Frontal lobe 0.80 0.93 0.90 0.88 0.75 0.97 0.82 0.93
OFC 0.97 0.80 0.98 0.80 0.93 0.88 0.96 0.83
DLPFC 0.88 0.72 0.78 0.72 0.83 0.92 0.83 0.78
Ant. Lat. Temporal lobe 0.98 0.95 0.92 0.92 0.65 0.43† 0.85 0.77
Medial Temporal 0.37† 0.85 0.33† 0.83 0.47† 0.72 0.39 0.80
Column Average 0.80 0.85 0.78 0.83 0.73 0.78 0.77 0.82
† indicates p value for correlation between manual and SABRE analysis ≥ .05BMC Nuclear Medicine 2007, 7:2 http://www.biomedcentral.com/1471-2385/7/2
Page 7 of 11
(page number not for citation purposes)
Table 3: Summary of average left-right ratios of 5-HT1aR BP values
Manual
M1A M1B M2
Frontal lobe 1.02 1.03 1.06
OFC 1.31 1.37 1.10†
DLPFC 1.04 1.04 0.97
Ant Lat Temporal Lobe 0.94 0.97 0.95
Medial Temporal 0.91 0.97 0.92
SABRE
S1A S1B S2
Frontal lobe 1.04 1.04 1.06
OFC 1.22 1.32 2.96
DLPFC 1.02 1.02 1.03
Ant Lat Temporal Lobe 1.01 1.01 1.01
Medial Temporal 0.90 1.02 1.02
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal
Lobe = anterior lateral temporal lobe
† Wilcoxon p < 0.05 vs. S1A
Table 4: Intra-rater reliability of intra-class correlation coefficients and repeatability coefficients
Manual (M1A-M1B)
Lt Rt
ICC RC RM % ICC RC RM %
Frontal lobe 0.99 0.46 6.33 1.00 0.43 6.02
OFC 1.00 0.73 6.92 1.00 0.86 7.51
DLPFC 1.00 0.68 6.58 0.99 0.43 4.31
Ant Lat Temporal lobe 0.98 0.35 4.52 0.98 0.46 6.11
Medial Temporal 0.98 1.09 11.74 1.00 0.34 3.31
Average 0.99 0.66 7.22 0.99 0.51 5.45
SABRE (S1A-S1B)
Lt Rt
ICC RC RM % ICC RC RM %
Frontal lobe 0.99 1.07 12.57 1.00 1.03 12.57
OFC 1.00 0.91 9.75 1.00 0.87 10.45
DLPFC 0.99 1.15 14.12 1.00 1.23 15.25
Ant Lat Temporal lobe 0.99 1.27 12.46 0.99 1.38 13.60
Medial Temporal 0.99 2.38 20.82 0.99 1.85 16.01
Average 0.99 1.36* 13.94* 0.99 1.27* 13.58*
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal
Lobe = anterior lateral temporal lobe
* p = 0.043 vs. manual results, Wilcoxon rank testBMC Nuclear Medicine 2007, 7:2 http://www.biomedcentral.com/1471-2385/7/2
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the anterior lateral temporal lobe. No cross-method com-
parisons were statistically significantly different.
Sensitivity to differentiate FTD patients from healthy 
comparison subjects
Average BP values of FTD patients did not differ from
those of healthy comparison subjects according to the
unpaired Student's t-test, regardless of the method used to
delineate ROIs. Cohen's d  values (effect sizes) for the
SABRE method were higher than for the manual method
across all ROIs (see Table 6). SABRE-derived d's exceeded
manually-derived d's with p < 0.05, except in the compar-
ison against rater M2. This particular finding supports the
lower inter-rater reliability of the manual method. Effect
sizes for left and right OFC were larger than for other
ROIs. As in Table 3, the right OFC BP from one subject
was thought to be an outlier. Values for right OFC effect
sizes when this subject was excluded still varied greatly,
reflecting the difficulty of measuring BP when the ROI is
very small: M1A 0.24, M1B -0.19, M2 -0.28, S1A -0.37,
S1B -0.39, and S2 -0.55.
Discussion
Prior studies have shown that automated methods of ROI
delineation can be accurate and time-saving for structural
volumetric analyses [8-11]. Our present results indicate
that the SABRE method also saves time for functional radi-
oligand PET analysis without altering the basic quality of
the results as compared to the gold standard, manual ROI
analysis. Intra-rater ICC and reliability were greater for
manual methods than SABRE, exceeding reliability crite-
ria pegging acceptable ICC values at a range of 0.75–0.80
[34]. Inter-rater ICC also met acceptable ICC value crite-
ria, with the exception of manual anterior lateral temporal
ROIs. The inter-rater reproducibility of PET results using
SABRE was at least as high as that using the manual
method. Although SABRE failed to significantly discrimi-
nate FTD patients from healthy comparison subjects,
which may be related to the small sample size, higher d
values for SABRE imply that SABRE can detect the
expected 5-HT1a R BP differences between FTD patients
and comparison subjects more sensitively than manual
analysis.
The image processing time savings are amplified for data-
sets where more than 15 slices are available: compared to
more current scanners that would afford 124 slices, our
approximately 3 hour difference between methods would
translate to at least an 8-hour saving (2 hours for SABRE
vs. at least a 10 hour manual task). 
Our results were very similar to those from the fully auto-
mated ROI extraction method of Rusjan et al. [35], except
that they were able to demonstrate higher intra- and inter-
Table 5: Inter-rater reliability intra-class correlation coefficients
Manual
M1A vs M2 M1B vs M2
Lt Rt Lt Rt
Frontal lobe 0.94 0.96 0.93 0.96
OFC 0.96 0.95 0.96 0.95
DLPFC 0.95 0.97 0.95 0.97
Ant Lat Temporal Lobe 0.50 0.62 0.57 0.67
Medial Temporal 0.98 0.98 0.94 0.99
A v e r a g e 0 . 8 70 . 9 00 . 8 70 . 9 1
SABRE
S1A vs S2 S1B vs S2
Lt Rt Lt Rt
Frontal lobe 0.99 1 0.96 0.97
OFC 0.99 0.98 0.98 0.99
DLPFC 0.69 0.65 0.97 0.78
Ant Lat Temporal Lobe 0.99 0.98 0.95 0.94
Medial Temporal 0.92 0.96 0.97 0.94
A v e r a g e 0 . 9 20 . 9 10 . 9 70 . 9 2
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal Lobe = anterior lateral temporal lobeBMC Nuclear Medicine 2007, 7:2 http://www.biomedcentral.com/1471-2385/7/2
Page 9 of 11
(page number not for citation purposes)
rater reliability for the automated method by virtue of full
automation obviating normal human variation. We
would have expected the SABRE method to grant advan-
tages over the fully automated method due to use of indi-
vidualized ROI extraction instead of subjecting MRI data
to a normalization procedure prior to co-registration with
the PET data, but we encountered problems with reliabil-
ity of SABRE in the temporal lobe regions. Both of our
studies recommend automated methods as a time-saving
method for ROI extraction without significant cost to
accuracy.  
Limitations of this study include low sample size and dif-
ficulty pinpointing the differences between methods spe-
cific to the manual vs. SABRE aspect. Ideally, a validation
study would include a larger group of imaging data, as
well as more inter-rater comparisons. Using a small
number may bias our search for similarity of data quality
in favor of SABRE. A larger sample would make the anal-
ysis less vulnerable to outliers. Only Mega et al.'s study [8]
included 20 subjects (more than twice our sample), con-
sisting of both patients with neurodegenerative disease
and controls.
Inclusion of both subjects with moderate to severe cortical
atrophy due to FTD and healthy controls with little or no
atrophy may have compensated for the small sample size
by creating a varied landscape over which both methods
had to perform, but the atrophic ROIs may have compli-
cated reproducibility of anterior lateral temporal, DLPFC,
and right OFC delineation. A further important limitation
is our method of correcting for partial volume effects, in
which we applied correction factors to the regional BPs
and not to the individual data points along the time activ-
ity curve (TAC). Our partial volume effect method suffices
for the purpose of our comparison, but most investigators
will perform partial volume effects compensation at an
earlier data modeling step.
Differences between the methods may be related to
aspects of image processing other than the actual delinea-
tion of the ROIs. We used Rview for co-registration of the
MRI to the PET images for the manually derived data and
AIR for the SABRE data. Software also differed for tracing
the ROIs: manual raters used Alice; SABRE raters used
ANALYZE. These software variations are difficult to
include as covariates in the analysis and cannot be ruled
Table 6: Cohen's measure for effect size using manual versus SABRE analysis to differentiate FTD from controls
Manual
M1A M1B M2
Lt Rt Lt Rt Lt Rt
Frontal lobe 0.11 0.08 0.19 0.18 -0.32 -0.01
OFC -0.15 -0.58 -0.25 -0.54 -0.24 -0.64
DLPFC -0.04 0.08 -0.01 0.12 0.25 0.29
Ant Lat Temporal Lobe -0.22 -0.06 -0.20 -0.09 0.74 0.71
Medial Temporal -0.01 -0.19 0.22 -0.20 -0.24 -0.42
Average -0.06 -0.13 -0.01 -0.11 -0.26 -0.30
SABRE
S1A S1B S2
Lt Rt Lt Rt Lt Rt
Frontal lobe -0.39 -0.49 -0.43 -0.52 -0.37 -0.50
OFC -0.80 -0.70 -0.85 -0.76 -0.71 -0.89
DLPFC -0.17 -0.36 -0.34 -0.54 -0.57 -0.84
Ant Lat Temporal Lobe -0.24 -0.20 -0.32 -0.28 -0.29 -0.15
Medial Temporal -0.29 -0.02 -0.29 -0.49 -0.33 -0.28
Average -0.38* -0.35 -0.45* -0.52† -0.45* -0.53†
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal
Lobe = anterior lateral temporal lobe
* p < 0.05 vs. left M1A & M1B
† p < 0.05 vs. right M1A & M1BBMC Nuclear Medicine 2007, 7:2 http://www.biomedcentral.com/1471-2385/7/2
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out as confounders. It would be difficult to conceive of a
significant impact of the software upon the time saved in
image processing.
The validation results reported here only apply to this spe-
cific experimental setup. It is not known how the accuracy
of the procedure is affected by errors in MRI segmentation
and/or MRI-PET coregistration, which differ when other
radiotracers or segmentation and coregistration strategies
are used.
Our findings that SABRE saved time over manual drawing
of multiple ROIs are not surprising; the most similar stud-
ies in the literature are in agreement [8-11]. Because struc-
tural landmarks are the bases of ROIs processed in the
interpretation of PET images, it seemed consistent to find
that reproducibility for the SABRE method was equivalent
to manual methods. The SABRE method requires identifi-
cation of fewer anatomical landmarks (15), as opposed to
boundaries for each of 10 ROIs in the manual process
(approximately 60 localizations, see Appendix) and there-
fore should leave less room for variation between raters.
Ashton et al.'s valid concern about error due to the track-
ing between slices required from 2D techniques [10]
could not be evaluated in our comparison, as derivation
of data for the BP measurements uses 2D techniques and
would therefore be exposed to the same types of edge
detection limitations.
Conclusion
This first account of semi-automated ROI delineation
improving on manual methods in processing functional
neuroimaging data validates the use of SABRE for future
PET studies where the analysis relies upon hypothesis-
based inquiry of ROIs. Investigators are cautioned about
the potential for reduced reliability using either method
when studying ROIs featuring marked atrophy in patient
subjects.
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